Bristol Myers Squibb, the manufacturer of the blood thinning drug Coumadin, has strengthened its warning label concerning the dangers of potentially fatal bleeding. Coumadin, known generically as Warfarin, had previously cited a "risk of hemorrhage" and wasn't highlighted in a black box.
You can ping this entry by using http://www.saundersblog.com/cgi-bin/mt/mt-tb.cgi/79 .